Please login to the form below

Not currently logged in
Email:
Password:

Xyphos

This page shows the latest Xyphos news and features for those working in and with pharma, biotech and healthcare.

Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal

Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal

Under the terms of the deal, Xyphos will be paid $120m upfront, with milestone payments worth up to $665m. ... In return, Astellas will gain Xyphos’ cell therapy technology platform and its expert research team.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....